The depletion of SRSF1 provides a unique opportunity to investigate manipulated disease-modifying mechanisms through the identification of gene expression changes that occur in both C9ORF72-ALS and upon neuroprotection. The gene discussed is SRSF1; the disease is amyotrophic lateral sclerosis.